Marine JARY

15
Documents

Publications

Publications

Image document

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

Thierry André , David Tougeron , Guillaume Piessen , Christelle de La Fouchardière , Christophe Louvet et al.
Journal of Clinical Oncology, 2023, 41 (2), pp.255-265. ⟨10.1200/JCO.22.00686⟩
Article dans une revue hal-03975142 v1

Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients (pts) with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma (OGA): The GERCOR NEONIPIGA phase II study

Thierry Andre , David Tougeron , Guillaume Piessen , Christelle de La Fouchardiere , Christophe Louvet et al.
Journal of Clinical Oncology, 2022, 40 (4), pp.244-244. ⟨10.1200/JCO.2022.40.4_suppl.244⟩
Article dans une revue hal-03657929 v1
Image document

The immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study

Marine Jary , Wen‐wei Liu , Dongyao Yan , Isaac Bai , Andrea Muranyi et al.
Molecular Oncology, 2021, ⟨10.1002/1878-0261.13173⟩
Article dans une revue hal-03510003 v1
Image document

Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment

Brice Pastor , André Thierry , Julie Henriques , Isabelle Trouilloud , Christophe Tournigand et al.
Molecular Oncology, 2021, 15 (9), pp.2401-2411. ⟨10.1002/1878-0261.12972⟩
Article dans une revue hal-03216431 v1
Image document

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

Laura Mansi , Laurie Spehner , Etienne Daguindau , Kevin Bouiller , Hamadi Almotlak et al.
European Journal of Cancer, 2021, 150, pp.1-9. ⟨10.1016/j.ejca.2021.03.033⟩
Article dans une revue hal-03364202 v1
Image document

Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial

Stefano Kim , Bruno Buecher , Thierry André , Marine Jary , François-Clément Bidard et al.
BMC Cancer, 2020, 20 (1), pp.352. ⟨10.1186/s12885-020-06841-1⟩
Article dans une revue hal-03130294 v1
Image document

Patients atteints d’un cancer gastrique localisé MSI/dMMR, pas de chimiothérapie mais une immunothérapie périopératoire : l’essai de phase II GERCOR NEONIPIGA vient d’être ouvert au recrutement

Romain Cohen , Thomas Pudlarz , Marie-Line Garcia-Larnicol , Dewi Vernerey , Xavier Dray et al.
Bulletin du Cancer, 2020, 107 (4), pp.438-446. ⟨10.1016/j.bulcan.2019.11.016⟩
Article dans une revue hal-02995557 v1
Image document

Mesure de la réponse radiologique scannographique des cancers colorectaux métastatiques : état des lieux et perspectives

Achille Fabre , Nicolas Badet , Paul Calame , Eric Delabrousse , Mylène Wespiser et al.
Bulletin du Cancer, 2019, 106, pp.1029 - 1038. ⟨10.1016/j.bulcan.2019.08.013⟩
Article dans une revue hal-03488393 v1

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Stefano Kim , Eric François , Thierry André , Emmanuelle Samalin , Marine Jary et al.
Lancet Oncology, 2018, 19 (8), pp.1094 - 1106. ⟨10.1016/S1470-2045(18)30321-8⟩
Article dans une revue hal-01863908 v1
Image document

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment

Sindy Vrecko , David Guenat , Patricia Mercier-Letondal , Hugues Faucheu , Magalie Dosset et al.
Oncotarget, 2018, 9 (83), pp.35394-35407. ⟨10.18632/oncotarget.26247⟩
Article dans une revue hal-01953497 v1
Image document

A systematic review of economic evaluation in pancreatic ductal adenocarcinoma

Claire Gérard , Philippe Fagnoni , Angélique Vienot , Christophe Borg , Samuel Limat et al.
European Journal of Cancer, 2017, 86, pp.207 - 216. ⟨10.1016/j.ejca.2017.08.035⟩
Article dans une revue inserm-01620966 v1

Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells

Jeanne Galaine , Guillaume Guillaume , Yves Guillaume , Romain Boidot , Emilie Picard et al.
Journal of Immunology, 2016, 197 (5), pp.1597 - 1608. ⟨10.4049/jimmunol.1502633⟩
Article dans une revue hal-01407427 v1
Image document

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.

Marine Jary , Dewi Vernerey , Thierry Lecomte , Erion Dobi , François Ghiringhelli et al.
Cancer Epidemiology, Biomarkers and Prevention, 2015, 24 (3), pp.603-12. ⟨10.1158/1055-9965.EPI-14-1059⟩
Article dans une revue inserm-01139951 v1
Image document

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.

Frédéric Fiteni , Marine Jary , Franck Monnien , Thierry Nguyen , Eric Beohou et al.
BMC Gastroenterology, 2013, pp.143
Article dans une revue inserm-01096384 v1
Image document

Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.

Stefano Kim , Erion Dobi , Marine Jary , Franck Monnien , Elsa Curtit et al.
BMC Cancer, 2013, 13 (1), pp.611. ⟨10.1186/1471-2407-13-611⟩
Article dans une revue inserm-00922823 v1